Key Findings:  There was a slightly increased incidence of Autism Spectrum Disorder (ASD) with self-reported peri-pregnancy cannabis use, however, it did not differ significantly from other developmental disorders (DD), nor the control group: 5.2% of ASD group, 3.2% of DD group, and 4.4% of the control group. Further research is needed to evaluate the true risk of peri-natal cannabis exposure.
Type of Study:  Meta-analysis
Study Sample Size:  4254
Study Result:  Negative
Study Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable